{"entity":{"type":"insider","cik":"0001714425","url":"/insider/0001714425","json_url":"/insider/0001714425.json","name":"van Elsas Andrea","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":14,"first":"2017-09-14","last":"2020-02-26","span_basis":"filed_date"},"name_variants":[{"name":"van Elsas Andrea","source":"filing","n_filings":14,"first_seen":"2017-09-14","last_seen":"2020-02-26"}],"transactions":[{"id":2581665,"accession":"0001567619-20-004897","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-20-004897","line_url":"/filing/0001567619-20-004897#line-1","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001714425","owner_name":"van Elsas Andrea","owner_display_name":"van Elsas Andrea","owner_url":"/insider/0001714425","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6823.0,"shares_display":"6,823","price_per_share":3.5107,"price_display":"3.51","price_state":"stated","total_value":23953.5061,"total_display":"23,953.51","total_whole":"23,954","shares_owned_after":438367.0,"shares_owned_after_display":"438,367","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-25","filed_date":"2020-02-26","scope":"insider"},{"id":2947692,"accession":"0001567619-20-000643","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-20-000643","line_url":"/filing/0001567619-20-000643#line-1","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001714425","owner_name":"van Elsas Andrea","owner_display_name":"van Elsas Andrea","owner_url":"/insider/0001714425","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":73311.0,"shares_display":"73,311","price_per_share":1.1882,"price_display":"1.19","price_state":"stated","total_value":87108.1302,"total_display":"87,108.13","total_whole":"87,108","shares_owned_after":445190.0,"shares_owned_after_display":"445,190","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-03","filed_date":"2020-01-06","scope":"insider"},{"id":7897960,"accession":"0001567619-19-023142","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-19-023142","line_url":"/filing/0001567619-19-023142#line-1","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001714425","owner_name":"van Elsas Andrea","owner_display_name":"van Elsas Andrea","owner_url":"/insider/0001714425","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2192.0,"shares_display":"2,192","price_per_share":1.1633,"price_display":"1.16","price_state":"stated","total_value":2549.9536,"total_display":"2,549.95","total_whole":"2,550","shares_owned_after":518501.0,"shares_owned_after_display":"518,501","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-12","filed_date":"2019-12-16","scope":"insider"},{"id":7791482,"accession":"0001567619-19-018456","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-19-018456","line_url":"/filing/0001567619-19-018456","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001714425","owner_name":"van Elsas Andrea","owner_display_name":"van Elsas Andrea","owner_url":"/insider/0001714425","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18593.0,"shares_display":"18,593","price_per_share":1.3058102296563223,"price_display":"1.31","price_state":"stated","total_value":24278.9296,"total_display":"24,278.93","total_whole":"24,279","shares_owned_after":521327.0,"shares_owned_after_display":"521,327","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-13","filed_date":"2019-09-17","scope":"insider","n_lines":2},{"id":8018203,"accession":"0001567619-19-007394","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-19-007394","line_url":"/filing/0001567619-19-007394#line-1","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001714425","owner_name":"van Elsas Andrea","owner_display_name":"van Elsas Andrea","owner_url":"/insider/0001714425","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6081.0,"shares_display":"6,081","price_per_share":3.9643,"price_display":"3.96","price_state":"stated","total_value":24106.9083,"total_display":"24,106.91","total_whole":"24,107","shares_owned_after":239557.0,"shares_owned_after_display":"239,557","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-19","filed_date":"2019-03-21","scope":"insider"},{"id":8336021,"accession":"0001567619-19-005538","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-19-005538","line_url":"/filing/0001567619-19-005538#line-1","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001714425","owner_name":"van Elsas Andrea","owner_display_name":"van Elsas Andrea","owner_url":"/insider/0001714425","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6844.0,"shares_display":"6,844","price_per_share":4.2548,"price_display":"4.25","price_state":"stated","total_value":29119.8512,"total_display":"29,119.85","total_whole":"29,120","shares_owned_after":245638.0,"shares_owned_after_display":"245,638","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-26","filed_date":"2019-02-27","scope":"insider"},{"id":6161062,"accession":"0001567619-18-008822","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-18-008822","line_url":"/filing/0001567619-18-008822#line-1","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001714425","owner_name":"van Elsas Andrea","owner_display_name":"van Elsas Andrea","owner_url":"/insider/0001714425","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1907.0,"shares_display":"1,907","price_per_share":2.57,"price_display":"2.57","price_state":"stated","total_value":4900.99,"total_display":"4,900.99","total_whole":"4,901","shares_owned_after":252482.0,"shares_owned_after_display":"252,482","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-28","filed_date":"2018-12-31","scope":"insider"},{"id":6581741,"accession":"0001567619-18-008011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-18-008011","line_url":"/filing/0001567619-18-008011#line-1","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001714425","owner_name":"van Elsas Andrea","owner_display_name":"van Elsas Andrea","owner_url":"/insider/0001714425","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2171.0,"shares_display":"2,171","price_per_share":2.932,"price_display":"2.93","price_state":"stated","total_value":6365.372,"total_display":"6,365.37","total_whole":"6,365","shares_owned_after":254389.0,"shares_owned_after_display":"254,389","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-12","filed_date":"2018-12-14","scope":"insider"},{"id":6166985,"accession":"0001567619-18-003110","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-18-003110","line_url":"/filing/0001567619-18-003110#line-1","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001714425","owner_name":"van Elsas Andrea","owner_display_name":"van Elsas Andrea","owner_url":"/insider/0001714425","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7726.0,"shares_display":"7,726","price_per_share":5.8273,"price_display":"5.83","price_state":"stated","total_value":45021.7198,"total_display":"45,021.72","total_whole":"45,022","shares_owned_after":256560.0,"shares_owned_after_display":"256,560","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-24","filed_date":"2018-09-25","scope":"insider"},{"id":6581525,"accession":"0001567619-18-002683","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-18-002683","line_url":"/filing/0001567619-18-002683#line-2","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001714425","owner_name":"van Elsas Andrea","owner_display_name":"van Elsas Andrea","owner_url":"/insider/0001714425","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9754.0,"shares_display":"9,754","price_per_share":6.4993,"price_display":"6.50","price_state":"stated","total_value":63394.1722,"total_display":"63,394.17","total_whole":"63,394","shares_owned_after":264286.0,"shares_owned_after_display":"264,286","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-13","filed_date":"2018-09-14","scope":"insider"},{"id":6390396,"accession":"0001140361-18-032937","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-032937","line_url":"/filing/0001140361-18-032937#line-1","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001714425","owner_name":"van Elsas Andrea","owner_display_name":"van Elsas Andrea","owner_url":"/insider/0001714425","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10454.0,"shares_display":"10,454","price_per_share":6.9641,"price_display":"6.96","price_state":"stated","total_value":72802.7014,"total_display":"72,802.70","total_whole":"72,803","shares_owned_after":206215.0,"shares_owned_after_display":"206,215","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-17","filed_date":"2018-07-19","scope":"insider"},{"id":6356836,"accession":"0001209191-18-014228","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-014228","line_url":"/filing/0001209191-18-014228#line-1","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001714425","owner_name":"van Elsas Andrea","owner_display_name":"van Elsas Andrea","owner_url":"/insider/0001714425","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6874.0,"shares_display":"6,874","price_per_share":6.4768,"price_display":"6.48","price_state":"stated","total_value":44521.5232,"total_display":"44,521.52","total_whole":"44,522","shares_owned_after":216669.0,"shares_owned_after_display":"216,669","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-26","filed_date":"2018-02-27","scope":"insider"},{"id":9270508,"accession":"0001209191-17-066067","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-066067","line_url":"/filing/0001209191-17-066067#line-1","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001714425","owner_name":"van Elsas Andrea","owner_display_name":"van Elsas Andrea","owner_url":"/insider/0001714425","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4922.0,"shares_display":"4,922","price_per_share":10.9858,"price_display":"10.99","price_state":"stated","total_value":54072.1076,"total_display":"54,072.11","total_whole":"54,072","shares_owned_after":202581.0,"shares_owned_after_display":"202,581","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-13","filed_date":"2017-12-15","scope":"insider"},{"id":4111258,"accession":"0001209191-17-052892","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-052892","line_url":"/filing/0001209191-17-052892#line-2","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001714425","owner_name":"van Elsas Andrea","owner_display_name":"van Elsas Andrea","owner_url":"/insider/0001714425","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4922.0,"shares_display":"4,922","price_per_share":10.9858,"price_display":"10.99","price_state":"stated","total_value":54072.1076,"total_display":"54,072.11","total_whole":"54,072","shares_owned_after":207231.0,"shares_owned_after_display":"207,231","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-13","filed_date":"2017-09-14","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":15,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001435049","name":"ADURO BIOTECH, INC.","url":"/issuer/0001435049","role":"Officer (Chief Scientific Officer)","n_filings":14,"first_seen":"2017-09-14","last_seen":"2020-02-26"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001714425","retrieved_at":"2026-08-25T13:17:26+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}